Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886881 · ClinicalTrials.gov registry record
Air Optix Extended Wear Contact Lenses
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 505
- Enrollment target
NCT05886881: Completed study, sponsored by Alcon Research.
NCT05886881 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 505 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886881 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 505 participants
- Enrollment target
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as extended (overnight) wear.
Primary Outcome
The subject's chart will be reviewed for distance visual acuity at Year 1, defined as a visit which occurred 1 year (-2/+4 months) since baseline during which period the subject was wearing either the study or comparator lenses and a contact lens examination was performed. The Baseline visit is defined as the first office visit where an eye care practitioner provided an in-person office biomicroscopy exam to the patient before or during which a contact lens prescription for the study or comparat
Interventions
- DEVICE Lotrafilcon B spherical soft contact lenses
- DEVICE Lotrafilcon B spherical soft contact lenses with comfort additive
- DEVICE Lotrafilcon B toric soft contact lenses with comfort additive
- DEVICE Comfilcon A spherical soft contact lenses
- DEVICE Comfilcon A toric soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2025-04-15 |
What the finished NCT05886881 record still lists
NCT05886881 is an observational study that tracks outcomes without assigning an intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Lotrafilcon B spherical soft contact lenses is the first listed.
NCT05886881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05886881 about?
NCT05886881 is a clinical study titled "Air Optix Extended Wear Contact Lenses". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as extended (overnight) wear.
What is the current status of trial NCT05886881?
This trial is currently completed. The enrollment target is 505 participants. The study started on 2023-08-03. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT05886881?
The interventions under investigation include: Lotrafilcon B spherical soft contact lenses (DEVICE), Lotrafilcon B spherical soft contact lenses with comfort additive (DEVICE), Lotrafilcon B toric soft contact lenses with comfort additive (DEVICE), Comfilcon A spherical soft contact lenses (DEVICE), Comfilcon A toric soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05886881?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI